By Ian Walker


Germany's Merck KGaA is buying life-science company Mirus Bio for $600 million as it expands its life science business sector.

The life-sciences and electronics company said late Wednesday that it expects the deal to close in the third quarter of this year.

Mirus Bio, based in Madison, Wis., develops transfection reagents that help to introduce genetic materials into cells.

"This strategic acquisition is a further building block for accelerating growth in the break-through technologies of the future," Chairman and Chief Executive Belen Garijo said.


Write to Ian Walker at ian.walker@wsj.com


(END) Dow Jones Newswires

05-23-24 0112ET